RSNA 2019

A Deep Learning-Based CAD that Can Reduce False Negative Reports: A Preliminary Study in Health Screening Center

  • Dec. 2019
  • by Hyunho Park et. al.

To evaluate the clinical value of a deep learning-based computer-aided detection (DLCAD) model that can reduce false negative reports on screening chest CTs that were considered normal.

A DLCAD consisting of a 2.5D CNN for candidate detection and a 3D CNN for false positive reduction was trained with a public LIDC-IDRI dataset. Preliminary validation performance for the same dataset was 90.7% sensitivity under one false-positive per scan threshold. Ten thousand low dose chest CT cases that were reported normal were collected from a single-center screening cohort from the year 2011 to 2015. 'Normal' was defined as containing no malignant or benign lesions. The deep learning-based CAD analyzed these cases reported as normal and detected nodule candidates. Four radiologists reviewed the results of CAD independently. When the candidate nodule was accepted, the type (solid, part-solid and ground-glass nodule [GGN]) and size of nodules were annotated.

DLCAD analyzed 9952 cases (48 cases with inappropriate parameters, scan range or field of view were excluded) and detected 471 nodule candidates. Among them, 283 nodules from 269 patients were reported to be the true nodules by more than three radiologists. Excluding 67 nodules (with insufficient consensus), 216 nodules were categorized to be the same diameter range and nodule type by more than three radiologists. Among 216 nodules, 151 (69.9%) nodules were solid, three (1.4%) were part-solid, and 62 (28.7%) were GGN. Among 151 solid nodules, 10 (6.6%) nodules were larger than or equal to 6mm (eight [5.3%] 6 to 8mm, two [1.3%] 8 to 15mm) and 141 (93.4%) were smaller than 6mm. All three part-solid nodules were smaller than 6mm. All 62 GGN were smaller than 20mm. According to the Lung-RADS, two solid nodules were category 4A, eight solid nodules were category 3, and the remaining 206 nodules were category 2.

The deep learning-based CAD has detected 2.7% (269/9952) false negative cases with neglected nodules. 4.6% (10/216) nodules were higher than Lung-RADS category 3, which require follow up scans.

The deep learning-based CAD will perform an ancillary role as a safeguard and a competent second reader by reducing false negative rates.


Hyunho Park, MD, Soo-Young Ham, MD, PhD, Hwa-Young Kim, MD, Hyon Joo Kwag, MD, Seungho Lee, MS, Gwangbeen Park, MS, Sangkeun Kim, MS, Minsuk Park, MS, Jin-Kyeong Sung, MD, PhD, Kyu-Hwan Jung, PhD

Tag in


#VUNO Med®-LungCT AI™